Penn Medicine and Virtua announced their plans to build a $35 million proton facility on Virtua Voorhees’ campus in southern New Jersey.
“Penn has established itself as a global leader in proton therapy both for the treatment of patients and the training of other medical professionals, and now we’re excited to spread that expertise to residents of South Jersey,” said Ralph Muller, CEO of the University of Pennsylvania Health System in a press release. “In partnership with Virtua, this center will usher in a new era of cancer treatment in South Jersey and give patients access to cutting edge care without having to come to Pennsylvania.”
The new center will allow patients to receive proton treatment, a less invasive form of cancer treatment than chemotherapy.
The center, which is expected to be completed by 2020, will be the first and only one of its kind in South Jersey.
These kinds of developments are what make the Greater Philadelphia region a global leader in life sciences and health care treatment.